Oral nanomedicine approaches for the treatment of psychiatric illnesses

Psychiatric illnesses are a leading cause of disability and morbidity globally. However, the preferred orally dosed pharmacological treatment options available for depression, anxiety and schizophrenia are often limited by factors such as low drug aqueous solubility, food effects, high hepatic first...

Ausführliche Beschreibung